SmartPill U.S. company has developed a wireless ingestible medical device SmartPill gastrointestinal (GI) Monitoring System, now the system has received U.S. Food and Drug Administration (FDA) for permission to use in the U.S..
The system size as a large vitamin pill, helps a comprehensive diagnosis of gastroparesis syndrome. Gastroparesis syndrome can affect many patients, including about 50% of diabetes and Parkinson\\ s disease.
Gastroparesis syndrome called gastroparesis symptoms, also known as stomach weakness, stomach paralysis. To delayed gastric emptying is a clinical syndrome characterized, mainly as early satiety, postprandial bloating or weight loss episodes of retching, the clinical examination found no organic damage to the gastrointestinal tract.